Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
06:23:40 EDT Thu 02 May 2024
Enter Symbol
or Name
USA
CA



News for U:ATBPF from 2023-05-03 to 2024-05-02 - 18 items News ReleasesIn The NewsOther CAUS
DateSymPriceTypeHeadline
2024-04-09 19:00U:ATBPFNews ReleaseAntibe Announces Granting of Initial Order Under Companies' Creditors Arrangement Act
2024-04-09 07:00U:ATBPFNews ReleaseAntibe to File an Application for an Initial Order Under Companies' Creditors Arrangement Act
2024-04-01 07:00U:ATBPFNews ReleaseAntibe Announces FDA Clinical Hold on Otenaproxesul and Legal Action by Nuance
2024-03-20 07:00U:ATBPFNews ReleaseAntibe to Present Otenaproxesul PK/PD Results at the ASRA Pain Medicine Meeting
2024-03-07 07:00U:ATBPFNews ReleaseAntibe to Present Otenaproxesul PK/PD Results at the American Academy of Pain Medicine Meeting
2024-03-04 07:00U:ATBPFNews ReleaseAntibe Announces Unfavorable Decision in Arbitration With Nuance Pharma
2024-02-14 07:00U:ATBPFNews ReleaseAntibe Reports Q3 2024 Interim Financial and Operating Results
2024-02-01 07:00U:ATBPFNews ReleaseAntibe Extends Early Warrant Exercise Incentive Program
2023-12-29 07:00U:ATBPFNews ReleaseAntibe Announces Early Warrant Exercise Incentive Program
2023-12-12 07:00U:ATBPFNews ReleaseAntibe Therapeutics Announces Amendment to Warrant Terms
2023-11-13 07:00U:ATBPFNews ReleaseAntibe Reports Q2 2024 Interim Financial and Operating Results
2023-11-09 07:00U:ATBPFNews ReleaseAntibe Reports PK Results of First Clinical Study of Otenaproxesul ¢ € ™s New Formulation
2023-11-01 07:00U:ATBPFNews ReleaseAntibe Completes First Clinical Study of Otenaproxesul ¢ € ™s New Formulation
2023-10-18 07:00U:ATBPFNews ReleaseAntibe Initiates First Clinical Study of Otenaproxesul ¢ € ™s New Formulation
2023-09-28 07:00U:ATBPFNews ReleaseAntibe Receives Approval to Initiate PK/PD Study of Otenaproxesul
2023-09-08 17:00U:ATBPFNews ReleaseAntibe Announces Results of 2023 Annual Meeting
2023-08-14 07:00U:ATBPFNews ReleaseAntibe Reports Q1 2024 Interim Financial and Operating Results
2023-06-29 07:30U:ATBPFNews ReleaseAntibe Reports 2023 Year-End Results and Business Highlights